Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer.

IF 2.7 4区医学 Q2 Medicine

Canadian Journal of Gastroenterology and Hepatology Pub Date : 2022-11-11 eCollection Date: 2022-01-01 DOI:10.1155/2022/4661929

Wenkai Jiang, Yan Du, Wenlong Zhang, Wence Zhou

{"title":"Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer.","authors":"Wenkai Jiang, Yan Du, Wenlong Zhang, Wence Zhou","doi":"10.1155/2022/4661929","DOIUrl":null,"url":null,"abstract":"Aim: The aim of this study is to identify cuproptosis-related lncRNAs and construct a prognostic model for pancreatic cancer patients for clinical use.Methods: The expression profile of lncRNAs was downloaded from The Cancer Genome Atlas database, and cuproptosis-related lncRNAs were identified. The prognostic cuproptosis-related lncRNAs were obtained and used to establish and validate a prognostic risk score model in pancreatic cancer.Results: In total, 181 cuproptosis-related lncRNAs were obtained. The prognostic risk score model was constructed based on five lncRNAs (AC025257.1, TRAM2-AS1, AC091057.1, LINC01963, and MALAT1). Patients were assigned to two groups according to the median risk score. Kaplan-Meier survival curves showed that the difference in the prognosis between the high- and low-risk groups was statistically significant. Multivariate Cox analysis showed that our risk score was an independent risk factor for pancreatic cancer patients. Receiver operator characteristic curves revealed that the cuproptosis-related lncRNA model can effectively predict the prognosis of pancreatic cancer. The principal component analysis showed a difference between the high- and low-risk groups intuitively. Functional enrichment analysis showed that different genes were involved in cancer-related pathways in patients in the high- and low-risk groups.Conclusion: The risk model based on five prognostic cuproptosis-related lncRNAs can well predict the prognosis of pancreatic cancer patients. Cuproptosis-related lncRNAs could be potential biomarkers for pancreatic cancer diagnosis and treatment.","PeriodicalId":48755,"journal":{"name":"Canadian Journal of Gastroenterology and Hepatology","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674419/pdf/","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2022/4661929","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 6

Abstract

Aim: The aim of this study is to identify cuproptosis-related lncRNAs and construct a prognostic model for pancreatic cancer patients for clinical use.

Methods: The expression profile of lncRNAs was downloaded from The Cancer Genome Atlas database, and cuproptosis-related lncRNAs were identified. The prognostic cuproptosis-related lncRNAs were obtained and used to establish and validate a prognostic risk score model in pancreatic cancer.

Results: In total, 181 cuproptosis-related lncRNAs were obtained. The prognostic risk score model was constructed based on five lncRNAs (AC025257.1, TRAM2-AS1, AC091057.1, LINC01963, and MALAT1). Patients were assigned to two groups according to the median risk score. Kaplan-Meier survival curves showed that the difference in the prognosis between the high- and low-risk groups was statistically significant. Multivariate Cox analysis showed that our risk score was an independent risk factor for pancreatic cancer patients. Receiver operator characteristic curves revealed that the cuproptosis-related lncRNA model can effectively predict the prognosis of pancreatic cancer. The principal component analysis showed a difference between the high- and low-risk groups intuitively. Functional enrichment analysis showed that different genes were involved in cancer-related pathways in patients in the high- and low-risk groups.

Conclusion: The risk model based on five prognostic cuproptosis-related lncRNAs can well predict the prognosis of pancreatic cancer patients. Cuproptosis-related lncRNAs could be potential biomarkers for pancreatic cancer diagnosis and treatment.

Abstract Image

查看原文本刊更多论文

基于胰腺癌杯突相关 lncRNA 标志构建预后模型

目的：本研究旨在鉴定杯突相关lncRNA，并构建胰腺癌患者的预后模型，供临床使用：方法：从癌症基因组图谱数据库中下载lncRNAs的表达谱，并鉴定杯突相关的lncRNAs。方法：从癌症基因组图谱数据库中下载lncRNAs表达谱，鉴定杯突相关lncRNAs，获得预后杯突相关lncRNAs，用于建立和验证胰腺癌预后风险评分模型：结果：共获得181个杯突症相关lncRNA。结果：共获得181个杯突症相关lncRNA，并根据5个lncRNA（ACE025257.1、TRAM2-AS1、AC091057.1、LINC01963和MALAT1）构建了预后风险评分模型。根据中位风险评分将患者分为两组。卡普兰-梅耶生存曲线显示，高危组和低危组的预后差异具有统计学意义。多变量 Cox 分析显示，我们的风险评分是胰腺癌患者的一个独立风险因素。接收者操作特征曲线显示，杯突相关lncRNA模型能有效预测胰腺癌的预后。主成分分析直观地显示了高风险组和低风险组之间的差异。功能富集分析表明，高危组和低危组患者的不同基因参与了癌症相关通路：基于五个预后杯突相关lncRNA的风险模型可以很好地预测胰腺癌患者的预后。杯突相关lncRNA可能成为胰腺癌诊断和治疗的潜在生物标志物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Canadian Journal of Gastroenterology and Hepatology GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

4.80

自引率

0.00%

发文量

审稿时长

37 weeks

期刊介绍： Canadian Journal of Gastroenterology and Hepatology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of gastroenterology and liver disease - medicine and surgery. The Canadian Journal of Gastroenterology and Hepatology is sponsored by the Canadian Association of Gastroenterology and the Canadian Association for the Study of the Liver.

文献相关原料

公司名称	产品信息	采购帮参考价格